Further, the CpG site cg18181703 (SOCS3) identified in our study, has been associated with metabolic syndrome (MetS) traits such as central obesity, fat depots, insulin responsiveness, and plasma lipids65, as well as type 2 diabetes incidence66. This evidence concerns the gene SOCS3 and Abdominal obesity.